9 3 7247
Pill imprint 9 3 7247 has been identified as Lamotrigine 150 mg.
Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; schizoaffective disorder; depression; anxiety (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy.
Lamotrigine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Lamotrigine Images
- Imprint:
-
9 3
7247 - Strength:
- 150 mg
- Color:
- Yellow
- Size:
- 14.00 mm
- Shape:
- Four-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
corn starch
sodium starch glycolate type A potato
ferric oxide yellow
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7247
Advertisement
More Lamotrigine resources
- Lamotrigine (Wolters Kluwer)
- Lamotrigine Chewable Dispersible Tablets (Wolters Kluwer)
- Lamotrigine Extended-Release Tablets (Wolters Kluwer)
- Lamotrigine Orally Disintegrating Tablets (Wolters Kluwer)
- lamotrigine (Cerner Multum)
- lamotrigine (Micromedex) - Includes Dosage Information
- Lamotrigine (AHFS DI)
- Lamotrigine (FDA)
- Lamotrigine Tablets (FDA)
- Lamotrigine (Wolters Kluwer)
Search Again
